U.S. Online Retail and Ecommerce Stock News

NasdaqGS:FRME
NasdaqGS:FRMEBanks

Is It Time To Reassess First Merchants (FRME) After Recent Share Price Stability?

If you are looking at First Merchants and wondering whether the current share price still represents good value, you are not alone. The stock last closed at US$42.05, with returns of 0.5% over the past 7 days, 11.7% over 30 days, 12.1% year to date and a 1% decline over the past year, which may signal changing expectations around its prospects and risk. This article was prompted by Simply Wall St's evergreen coverage of First Merchants, which periodically refreshes to keep valuation and...
NYSE:MNTN
NYSE:MNTNMedia

MNTN (MNTN) Turns First Quarterly Profit And Tests Bullish Narratives

MNTN (MNTN) has put a cleaner set of numbers on the table for FY 2025 so far, with Q3 revenue of US$70.0 million and basic EPS of US$0.09 off net income of US$6.4 million, against a trailing twelve month backdrop that still shows a loss of US$44.9 million on revenue of US$272.8 million and EPS of US$1.25. The company has seen quarterly revenue move from US$54.8 million in Q2 2024 to US$70.0 million in Q3 2025. EPS has swung across losses of US$0.69, US$1.41 and US$0.65 in early FY 2025 before...
NYSE:EW
NYSE:EWMedical Equipment

Edwards Lifesciences (EW) Margin Compression To 17.5% Tests Premium P/E Narrative

Edwards Lifesciences FY 2025 earnings snapshot Edwards Lifesciences (EW) has wrapped up FY 2025 with fourth quarter revenue of US$1,569.6 million and basic EPS of US$0.11, setting the tone for how investors assess the latest stretch of results. The company has seen revenue move from US$1,385.8 million in Q4 2024 to US$1,569.6 million in Q4 2025, while basic EPS over that same period went from US$0.59 to US$0.11. This puts the focus squarely on how efficiently those sales are translating into...
NYSE:DGX
NYSE:DGXHealthcare

Quest Diagnostics MRD Blood Test May Support Growth In Higher Value Oncology

Quest Diagnostics (NYSE:DGX) has introduced a blood based minimal residual disease test for multiple myeloma that uses advanced flow cytometry. The company reports that the assay offers sensitivity comparable to next generation sequencing with a lower expected cost and less invasive sampling. FDA draft guidance recognizes minimal residual disease as an endpoint in multiple myeloma clinical trials, supporting broader use of MRD testing in research. For you as an investor, this development...
NasdaqGS:GRAB
NasdaqGS:GRABTransportation

Grab’s First Profitable Year Resets Capital Returns And Growth Plans

Grab Holdings (NasdaqGS:GRAB) reports its first full year of net profit. The company launches a $500 million share buyback program. Grab announces the acquisition of Stash Financial to expand into wealth services. Grab partners with Hesai Technology to distribute lidar products across Southeast Asia. Grab Holdings is moving through a major shift, pairing its first full year of net profit with several new capital and business moves. The share price sits at $4.23, with a 3 year return of...
NYSE:AKR
NYSE:AKRRetail REITs

Acadia Leadership Transition Raises Questions On Reporting Strength And Growth

Acadia Realty Trust (NYSE:AKR) announced internal executive promotions tied to the planned retirement of its long-tenured Chief Administrative Officer, Joseph Napolitano. Erica Pipitone has been promoted to Vice President of Financial Reporting as part of the updated leadership structure. Napolitano is set to retire after 31 years with the company, marking a significant shift in its senior administrative team. Acadia Realty Trust focuses on retail real estate, so leadership in finance and...
NYSE:QGEN
NYSE:QGENLife Sciences

Qiagen’s Greener Lab Automation Push And What It Could Mean For Growth

Qiagen (NYSE:QGEN) has introduced sustainability-focused consumables and new automated sample preparation systems for clinical laboratories. The lineup features the newly launched QIAsprint Connect, with QIAsymphony Connect and QIAmini planned to broaden automation options across different lab sizes. The company is positioning these platforms to support greener lab workflows and greater process efficiency in clinical testing environments. Qiagen is putting more attention on automation and...
NasdaqGM:BWMN
NasdaqGM:BWMNConstruction

3 Growth Companies To Watch With Insider Ownership Up To 19%

As February begins, the U.S. stock market has shown a strong start with major indexes like the Dow Jones Industrial Average and S&P 500 posting significant gains, reflecting investor optimism amid recent economic developments such as trade agreements and manufacturing growth. In this buoyant market environment, identifying growth companies with substantial insider ownership can be particularly compelling for investors seeking alignment between company leadership and shareholder interests.
NasdaqCM:RPID
NasdaqCM:RPIDLife Sciences

February 2026's Standout Penny Stocks To Consider

As February begins, the U.S. stock market is off to a strong start, with major indexes like the Dow Jones and S&P 500 posting significant gains. In such a buoyant market environment, investors often look beyond traditional stocks for opportunities that might offer substantial returns at lower entry points. Penny stocks, while an outdated term, still represent an intriguing investment area where smaller or newer companies can provide growth potential when underpinned by solid financials and...
NasdaqGS:XNET
NasdaqGS:XNETSoftware

US Market's Undiscovered Gems To Watch In February 2026

As February 2026 begins, the U.S. stock market is experiencing a strong upswing, with major indexes like the Dow Jones Industrial Average and S&P 500 posting significant gains. This positive momentum comes amid broader economic developments such as trade deals and manufacturing growth, creating an environment ripe for identifying promising small-cap stocks that may have been overlooked. In this vibrant market landscape, a good stock often combines solid fundamentals with growth potential that...
NYSE:PFSI
NYSE:PFSIDiversified Financial

Is PennyMac Financial Services (PFSI) Offering Value After Its Recent Share Price Pullback?

Wondering if PennyMac Financial Services is starting to look like value at around US$90.40 a share, or if the recent weakness is a warning sign you should pay attention to? The stock has pulled back recently, with a 5.9% decline over the last 7 days, a 38.2% decline over the last 30 days, and a 31.3% decline year to date. However, the 3 year and 5 year returns of 40.0% and 46.6% tell a different part of the story. Recent news flow around mortgage originators and servicers has kept attention...
NasdaqCM:EVLV
NasdaqCM:EVLVElectronic

Can Evolv Technologies (EVLV) Turn New Venue Wins And Board Hire Into Stickier Subscription Security Revenue?

Evolv Technologies has recently expanded its Evolv Express deployments to high-traffic sports venues including the University of North Carolina’s athletic facilities and TQL Stadium, while also appointing Axon executive Henrik Kühl as an independent director and Audit Committee financial expert. Together, these venue wins and boardroom changes highlight Evolv’s push to deepen its presence in live-event security while adding seasoned capital allocation and M&A expertise to its...
NasdaqGS:WB
NasdaqGS:WBInteractive Media and Services

Weibo (WB) Valuation Check As Spring Festival Gala Partnership Renews Attention

Weibo (WB) is back in focus after being confirmed as the official copyright video partner for CCTV's 2026 Spring Festival Gala, while renewed investor interest highlights its valuation discount and sizeable China social media footprint. See our latest analysis for Weibo. Despite the renewed buzz around the Spring Festival Gala partnership and upcoming earnings call, Weibo’s recent share price performance has been subdued. The 1 month share price return shows a 9.27% decline and the 1 year...
NasdaqGS:LYFT
NasdaqGS:LYFTTransportation

Lyft (LYFT) One Time EPS Surge To US$6.88 Challenges Cautious Profitability Narratives

Lyft FY 2025 earnings snapshot Lyft (LYFT) has capped FY 2025 with fourth quarter revenue of US$1.6 billion and basic EPS of US$6.88, against a trailing twelve month EPS of US$6.92 on revenue of US$6.3 billion that reflects very large year over year earnings growth and a sharply higher net profit margin. Over the last few quarters, the company has seen revenue move from US$1.45 billion in Q1 2025 to US$1.69 billion in Q3 2025, while basic EPS shifted from roughly breakeven at US$0.01 in Q1 to...
NYSE:SLVM
NYSE:SLVMForestry

Should Weaker Q4 2025 Profitability Require Action From Sylvamo (SLVM) Investors?

Sylvamo Corporation has reported past fourth-quarter 2025 results, with sales of US$890 million and net income of US$33 million, both below the prior year’s levels. The sharp drop in basic earnings per share from continuing operations to US$0.84 from US$1.98 highlights a meaningful squeeze on profitability. We will now examine how this weaker quarterly profitability shapes Sylvamo’s existing investment narrative built around efficiency gains and cash generation. AI is about to change...
NYSE:CIM
NYSE:CIMMortgage REITs

A Look At Chimera Investment (CIM) Valuation After Dividend Hike Acquisition And Q4 Profit Update

Dividend hike, acquisition, and Q4 profit put Chimera in focus Chimera Investment (CIM) is back on income investors radar after a 22% increase to its common dividend, the Home Express Mortgage acquisition, and a profitable fourth quarter update. See our latest analysis for Chimera Investment. Those updates have come alongside a 6.42% 1 day share price return and a 4.72% 7 day share price return, while the 1 year total shareholder return of 5.30% contrasts with weaker 3 and 5 year total...
NYSE:PRI
NYSE:PRIInsurance

Primerica Dividend Hike Highlights Earnings Strength And Capital Return Balance

Primerica (NYSE:PRI) announced a 15% increase in its quarterly dividend. The dividend change follows the release of strong fourth quarter and full year results. The company reported earnings and revenue that surpassed analyst expectations. Primerica focuses on providing financial products such as term life insurance and investment solutions to middle income households. For investors watching the financial services sector, a double digit dividend increase can indicate that management views...
NasdaqGS:AZTA
NasdaqGS:AZTALife Sciences

Azenta’s Space Trials Put Sample Tools And Valuation In New Focus

Azenta (NasdaqGS:AZTA) has entered a partnership with Frontier Space to bring its sample management technologies into space-based life sciences research. The collaboration includes testing Azenta’s FluidX consumables in microgravity and other extreme space conditions. This move introduces Azenta’s solutions to space research programs that rely on reliable sample handling and storage. For investors following life sciences tools and services, Azenta sits in the middle of sample management and...
NYSE:FLNG
NYSE:FLNGOil and Gas

FLEX LNG (FLNG) Margins Hold At 28.1% Reinforcing Profitability Narrative

FLEX LNG (NYSE:FLNG) has put up another steady quarter, reporting Q3 FY 2025 revenue of US$85.7 million and basic EPS of US$0.31. This is backed by trailing twelve month revenue of US$351.0 million and EPS of US$1.82. The company has seen revenue move between US$84.7 million and US$90.9 million per quarter since mid 2024, while quarterly EPS has ranged from US$0.31 to US$0.84 over the same period. These figures feed into a 28.1% net margin and 7.2% earnings growth over the last year. Overall,...